FGFR3 INHIBITOR COMPOUNDS
The present invention provides compounds of the formula:, for use in the treatment of systemic sclerosis, fibrosis (e.g. pulmonary fibrosis), achondroplasia, thanatophoric dysplasia (e.g. type I), severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN), muenke syndrome or ca...
Saved in:
Main Authors | , , , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
09.09.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention provides compounds of the formula:, for use in the treatment of systemic sclerosis, fibrosis (e.g. pulmonary fibrosis), achondroplasia, thanatophoric dysplasia (e.g. type I), severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN), muenke syndrome or cancer.
La présente invention concerne des composés de formule : destinés à être utilisés dans le traitement de la sclérodermie généralisée, de la fibrose (par exemple, la fibrose pulmonaire), l'achondroplasie, la dysplasie thanatophore (par exemple, de type I), l'achondroplasie sévère avec un retard de développement et une acanthosis nigricans (SADDAN), le syndrome de Muenke ou le cancer. |
---|---|
AbstractList | The present invention provides compounds of the formula:, for use in the treatment of systemic sclerosis, fibrosis (e.g. pulmonary fibrosis), achondroplasia, thanatophoric dysplasia (e.g. type I), severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN), muenke syndrome or cancer.
La présente invention concerne des composés de formule : destinés à être utilisés dans le traitement de la sclérodermie généralisée, de la fibrose (par exemple, la fibrose pulmonaire), l'achondroplasie, la dysplasie thanatophore (par exemple, de type I), l'achondroplasie sévère avec un retard de développement et une acanthosis nigricans (SADDAN), le syndrome de Muenke ou le cancer. |
Author | METCALF, Andrew Terrance DILGER, Andrew Karl WALLS, Shane Michael URKALAN, Kaveri Balan KERCHER, Timothy Scott HAZLITT, Robert Alan BUME, Desta Doro CONDROSKI, Kevin Ronald ABRAHAM, Adedoyin David |
Author_xml | – fullname: METCALF, Andrew Terrance – fullname: WALLS, Shane Michael – fullname: CONDROSKI, Kevin Ronald – fullname: DILGER, Andrew Karl – fullname: ABRAHAM, Adedoyin David – fullname: KERCHER, Timothy Scott – fullname: URKALAN, Kaveri Balan – fullname: HAZLITT, Robert Alan – fullname: BUME, Desta Doro |
BookMark | eNrjYmDJy89L5WSQdHN3CzJW8PTz8HTyDPEPUnD29w3wD_VzCeZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRkaGFuYmJsaOhsbEqQIAZrUiqA |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | COMPOSÉS INHIBITEURS DE FGFR3 |
ExternalDocumentID | WO2022187443A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_WO2022187443A13 |
IEDL.DBID | EVB |
IngestDate | Fri Nov 01 05:39:17 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_WO2022187443A13 |
Notes | Application Number: WO2022US18644 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220909&DB=EPODOC&CC=WO&NR=2022187443A1 |
ParticipantIDs | epo_espacenet_WO2022187443A1 |
PublicationCentury | 2000 |
PublicationDate | 20220909 |
PublicationDateYYYYMMDD | 2022-09-09 |
PublicationDate_xml | – month: 09 year: 2022 text: 20220909 day: 09 |
PublicationDecade | 2020 |
PublicationYear | 2022 |
RelatedCompanies | ELI LILLY AND COMPANY |
RelatedCompanies_xml | – name: ELI LILLY AND COMPANY |
Score | 3.4185996 |
Snippet | The present invention provides compounds of the formula:, for use in the treatment of systemic sclerosis, fibrosis (e.g. pulmonary fibrosis), achondroplasia,... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | FGFR3 INHIBITOR COMPOUNDS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220909&DB=EPODOC&locale=&CC=WO&NR=2022187443A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-J0SkHpW7G26dfDEJu2tkKbUjvd21jaCILM4Sr--15Dp3vaW5KDywdc7n7JfQDcoBrlxlwYGuEIV9tshBqfC0erCK9s607oQlYtSTM7npCnqTXtwcc6FkbmCf2RyRFRoiqU90be18v_R6xA-laubvk7Dn3eR-U4UDt0bBi6p3tq4I_DnAWMqpQiblOzQtLa8nPEfECstIOGtNPKQ_jit3Epy02lEh3Cbo78Fs0R9MRiAPt0XXttAHtp9-WNzU76VscwjB6jwlSSLE78pGSFQlmas0kWPJ_AdRSWNNZwjtnflmavbHNB5in0EeyLM1CEsN-s2kOtYQjikpq7rnC4WwvuoOHBjSGMtnE6306-gIO2K32kvBH0m69vcYlKteFX8ix-AV7kdtQ |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq2K1akDJLRg370MR8zLR5kFMtbfQTbYgSC024t93sqTaU2_LDsw-4NvZb3ceADdoRimZMSKpFOlqk41QojNmSKVKS127YzLjVUuiWA8m6tNUm3bgYx0Lw_OE_vDkiIioEvFe8_N6-f-I5XLfytUtfceuz3s_H7liy44JkS3ZEl175KWJmzii4yBvE-OMy5ryc6rygFxpBy_ZRoMH79Vu4lKWm0bFP4DdFPUt6kPosEUfes669lof9qL2yxubLfpWRzDwH_1MEcI4CO0wTzLBSaI0mcTuyzFc-17uBBKOUfwtqXhLNieknEAXyT47BYExfa5VFloNwlRTrahpMoOaFaMGXjwoGcBwm6az7eIr6AV5NC7GYfx8DvuNiPtLWUPo1l_f7AINbE0v-b78AhvIecc |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=FGFR3+INHIBITOR+COMPOUNDS&rft.inventor=METCALF%2C+Andrew+Terrance&rft.inventor=WALLS%2C+Shane+Michael&rft.inventor=CONDROSKI%2C+Kevin+Ronald&rft.inventor=DILGER%2C+Andrew+Karl&rft.inventor=ABRAHAM%2C+Adedoyin+David&rft.inventor=KERCHER%2C+Timothy+Scott&rft.inventor=URKALAN%2C+Kaveri+Balan&rft.inventor=HAZLITT%2C+Robert+Alan&rft.inventor=BUME%2C+Desta+Doro&rft.date=2022-09-09&rft.externalDBID=A1&rft.externalDocID=WO2022187443A1 |